Real World Data Archives - Healthentia https://healthentia.com/tag/real-world-data/ Fri, 14 Nov 2025 14:45:39 +0000 en-US hourly 1 https://healthentia.com/wp-content/uploads/2020/04/cropped-favicon_512-32x32.png Real World Data Archives - Healthentia https://healthentia.com/tag/real-world-data/ 32 32 193384636 RE-SAMPLE Platform for training and use of COPD exacerbation risk prediction models https://healthentia.com/re-sample-platform-for-training-and-use-of-copd-exacerbation-risk-prediction-models/ Fri, 14 Nov 2025 14:45:39 +0000 https://healthentia.com/?p=22662 The post RE-SAMPLE Platform for training and use of COPD exacerbation risk prediction models appeared first on Healthentia.

]]>

CATEGORY: Poster

SOURCE: European Respiratory Journal 2024 64(suppl 68), https://doi.org/10.1183/13993003.congress-2024.PA2319

 

RE-SAMPLE Platform for training and use of COPD exacerbation risk prediction models

 

Alberto Acebes, Serge Autexier, Marjolein Brusse-Keizer, Agni Delvinioti, Thrasyvoulos Giannakopoulos, Christiane Grünloh, Florian Hahn, Rain Jögi, Christos Kalloniatis, Konstantina Kostopoulou, Sofoklis Kyriazakos, Kostas Lamprinoudakis, Jakob Lehmann, Danae Lekka, Anke Lenferink, Federico Mazzone, Giulio Pagliari, Stefano Patarnello, Aristodemos Pnevmatikakis, Jarno Raid, Monique Tabak, Job Van Der Palen, Gesa Wimberg

 

Background: Many COPD patients experience multiple chronic conditions increasing their burden, healthcare consumption and costs. Due to the interplay of the diseases and overlapping symptoms, disease management is complex.

Objective: Developing personalised exacerbation risk prediction models for shared decision-making based on combined models of clinical data and real-world data (RWD) to increase patient involvement.

Methods: Three collaborating European hospitals provided retrospective clinical data enriching holistic data of a current prospective cohort study. The RE-SAMPLE platform manages the clinical data and RWD collected by patients using the Healthentia App at edge nodes on-site in each hospital. This allows for privacy preserving federated training of machine learning (ML) models. The combined models are available in all hospitals to provide personalised predictions and explanations displayed in the clinical dashboard of the Healthentia portal app.

Results: Edge nodes enable the use of clinician front ends for monitoring and shared decision-making. Cooperative training of models is functional. The analysis of predictive models trained on retrospective data shows that the number of COPD exacerbations in the previous year is the most important predictor for COPD exacerbation risk within following year (single feature model accuracy 75.6% on a balanced dataset, n=1068). This is in line with literature and is evidence for the suitability of the models.

Conclusion: The RE-SAMPLE platform enables data storage, synchronisation and management for patient monitoring and privacy-preserving training of federated ML models suitable for use in shared-decision making in patients with COPD and comorbidities.

 

Keywords: COPD, Exacerbation Risk Prediction, Real-World Data, Clinical Data, Personalized Healthcare, Machine Learning, Patient Monitoring
 

 

More Publications

The post RE-SAMPLE Platform for training and use of COPD exacerbation risk prediction models appeared first on Healthentia.

]]>
22662
Advanced monitoring, alerting and feedback in early risk mitigation for pancreatic cancer https://healthentia.com/advanced-monitoring-alerting-and-feedback-in-early-risk-mitigation-for-pancreatic-cancer/ Tue, 04 Nov 2025 13:15:27 +0000 https://healthentia.com/?p=22593 The post Advanced monitoring, alerting and feedback in early risk mitigation for pancreatic cancer appeared first on Healthentia.

]]>

CATEGORY: Health Informatics Journal

SOURCE: Sage Journals, October 15, 2025, https://doi.org/10.1177/14604582251387969

 

Advanced monitoring, alerting and feedback in early risk mitigation for pancreatic cancer

George Manias1,2, Nelina Angelova3, Diana Kirova4, Aristodemos Pnevmatikakis3, Pencho Stefanov4, Fabio Melillo5, Oscar Garcia Perales6, Konstantina Kostopoulou3, Sofoklis Kyriazakos3, Dimosthenis Kyriazis1

 

1Department of Digital Systems, University of Piraeus, Pireas, Greece
2Jheronimus Academy of Data Science, Tilburg University, Tilburg, Netherlands
3Innovation Sprint, Brussels, Belgium
4Strypes ICT, Sofia, Bulgaria
5Engineering Ingegneria Informatica SpA, Rome, Italy
6Information Catalyst, SL, X`ativa, Spain
 
 

Abstract

A novel patient monitoring system is introduced, designed to support early risk mitigation in pancreatic cancer through personalized health interventions. The system aims to strengthen patient engagement and proactive care by enabling healthcare practitioners (HCP) to assign dynamic, data-driven and personalized mitigation plans. Central to this system is a user interface that allows HCP to review and assign tailored mitigation plans to patients. These plans are formulated based on primary clinical data and enriched with secondary behavioral data, such as wearable-derived metrics and self-reported inputs. These inputs are continuously collected, transformed into Holistic Health Records (HHRs), and stored in a scalable platform for integration with ML-based trend analysis and visualization. The article outlines the system’s technical architecture, patient data evaluation logic, and user experience across both the HCP interface and patient app. Evaluation by end users via questionnaires demonstrated improved adherence to plans and higher-quality behavioral data. This monitoring platform offers a promising tool for facilitating early risk intervention in pancreatic cancer care. By integrating multi-source patient data into actionable strategies and fostering bidirectional engagement, it bridges the gap between clinical insight and patient participation, contributing to holistic health management.
 

Introduction

The integration of internet and technology into healthcare has opened new horizons for patient care and disease management, marking a significant shift from traditional methods to more personalized and proactive approaches.13 The iHelp platform4 is one such comprehensive solution designed to augment the capabilities of HCPs across various domains of patient management. This innovative system consolidates multiple components to offer a range of functionalities aimed at enhancing patient care, predicting health outcomes, and promoting healthier lifestyles. The patient Monitoring, Alerting and Feedback (MA&F) subsystem is the part of the iHelp platform that tailors and delivers the treatment plans.
To arrive at this point though, iHelp involves a data collection and processing subsystem5 that provides the patient MA&F subsystem with the patient context, as it is mapped into proprietary Holistic Health Records (HHRs) stored in the BDP.6 The HHR data is analyzed towards early risk predictions and personalized prevention measures.7,8
Both raw and processed data is visualized in the Decision Support System (DSS) at the core of the iHelp platform. DSS is designed to support the dynamic needs of healthcare professionals and their patients. It acts as a central hub, providing seamless access to the platform’s diverse functionalities. HCPs can efficiently manage patient information, access predictive analytics, and implement personalized care plans without navigating through multiple applications or interfaces. Via DSS, the iHelp platform empowers HCPs to make informed decisions, tailor treatment plans, and manage potential risks more effectively.
Mitigation and action plans form the backbone of this patient care delivery and focus on promoting a healthier lifestyle and behavioral change in patients, while also tackling known comorbidities of the disease. Recognizing the impact of lifestyle choices on overall health, and the impact digital therapeutics have in managing, preventing and treating various conditions in the modern world,13 the MA&F subsystem of iHelp enables the assignment of customized action plans. These plans are designed to encourage positive health behaviors and are delivered through Healthentia,912 a patient companion app and its associated supporting backend services. The data collected and visualized through the Healthentia app includes both real world data (RWD) measurements (from integrated IoT devices like activity trackers) and self-reports (questionnaires, manual input records). Observed fluctuations on the latest data entries connected to an action plan shape future personalized care giving. Care delivery is also done via the Healthentia mobile app, namely its virtual coach9 that delivers dialogues to the patients. These dialogues offer continuous support and motivation, information on achievement or failure for the past period’s actions, and educational content. All dialogues are curated by experts and are triggered by the MA&F subsystem of iHelp and the supervision of the HCPs. This aspect of the iHelp system is instrumental in engaging patients in their own health management, fostering adherence to health recommendations, and ultimately leading to improved health outcomes.
The integration of these diverse functionalities within a single DSS represents a significant advancement in healthcare technology. The iHelp platform exemplifies how digital solutions can transform patient care, offering a more personalized, predictive, and participatory approach to healthcare. By equipping HCPs with the tools to remotely manage their patients and promote healthier lifestyles, the iHelp platform addresses the multifaceted nature of patient care in the digital age. This introduction sets the stage for a detailed exploration of the iHelp platform’s monitoring, alerting and feedback components, showcasing their operation and impact on healthcare delivery.
 

Methodology

The MA&F subsystem is used in different studies of iHelp related to pancreatic cancer. The studies have diverse aims falling into two groups: (i) individuals that are coached into healthier lifestyles to reduce their risk, and (ii) patients that are coached towards improved quality of life.
 
The MA&F subsystem functionality is delivered by four components. Two of them, the Monitoring & Alerting and the impact evaluator components are located in the iHelp BDP. The other two, the Smart Profiler and Virtual Coach components are part of Healthentia and are utilized by iHelp. The Monitoring & Alerting component is the starting point, as it manages the personalized care plans. Then, the Smart Profiler understands the patient context and the Virtual Coach handles the interaction of the patient with the delivered content. Finally, the Impact Evaluator understands the effect of the content delivered to the patient. These components are detailed in the following sub-sections.

 

Monitoring and alerting
The Monitoring and Alerting component facilitates the management and improvement of patient health through personalized action plans, leveraging both primary and secondary data sources. Primary data includes direct inputs from healthcare providers, whereas secondary data is gathered from wearable devices and questionnaires, tracking a range of configurable metrics such as physical activity, smoking habits, pain intensity and more. Although not all patients in the iHelp pilot studies are adhering to the data collection plans, it is established that the majority of patients would share their data with their HCP in long-term prevention activities.13 Figure 1 depicts the iHelp platform architecture and within it the Monitoring and Alerting component.
 
Figure 1. Overall iHelp Architecture, highlighting the two iHelp components of the MA&F subsystem, the Monitoring & Alerting and the Impact evaluator.
 
The mechanism has a two-fold objective, as it aims to optimize decision support for HCPs, while also offering improved personalization of risk mitigation and prevention plans through the fine-tuning of goal settings. To achieve the latter, four subcomponents are designed and developed, embodying a microservices architecture: the BDP Connector, the Data Aggregator, the Data Evaluator, and the Alert Generator that implement the monitoring, evaluating and alerting functionalities. These microservices are communicating through Apache Kafka,14 a distributed event streaming platform that ensures high throughput, fault tolerance, and seamless scalability. Kafka enables the microservices to handle large volumes of data efficiently, making the system robust and adaptable to varying loads, which is essential for the dynamic environment of healthcare data processing. The latter is highly crucial especially in the case of exchanging (near) real-time streaming data. A respective performance evaluation during load testing showed the system can handle over 5000 messages per minute with latency below 100 ms per message under peak load.
The mechanism also provides a mitigation plans API for managing the CRUD (Create, Read, Update, Delete) operations related to the action plans and rules and their assignment to patients, controlling the lifecycle of action plans and rules tailored to individual patient needs. This microservice is integral to both the React-based frontend, providing a user-friendly interface for HCPs as part of the DSS, and the backend, where it interfaces with other microservices to ensure seamless operation and data flow. The BDP Connector acts as the bridge between the iHelp BDP and the internal workings of the monitoring system. Its primary role is to facilitate the secure and reliable extraction of patient data from the big data platform, making it available for further processing. This microservice is critical in the initial step of data collection, ensuring that comprehensive and up-to-date patient information is consistently fed into the system for analysis. Following data retrieval, the Data Aggregator microservice takes center stage. It is programmed to collect data related to each action plan and its rules at predetermined intervals from the BDP Connector. The aggregator systematically organizes this information, preparing it for detailed evaluation. This process involves compiling data relevant to individual patient health goals, setting the stage for a personalized analysis.
Next, the Data Evaluator microservice represents the analytical core of the system, where the aggregated data undergoes scrutiny against predefined rules tailored to each patient’s health objectives. This evaluation determines whether the patient’s activities and health metrics align with their targeted health outcomes, such as medication adherence or physical activity levels. Utilizing Kafka for real-time data processing, the Data Evaluator ensures that the analysis is both timely and reflective of the latest data, crucial for accurate health monitoring and intervention.
Upon completion of the evaluation, the Alert Generator microservice is responsible for the delivery of personalized feedback to patients through a dedicated API to Healthentia’s Smart Profiler that triggers the Virtual Coach. As a result, the Healthentia mobile app provides messages and dialogues aiming to convey the evaluation results in a personalized, understandable, and actionable manner, encouraging patients towards healthier behaviors and goal achievement and giving them further information on the benefits of healthy habits.
Additionally, the Data Generator microservice archives an overview of these communications within the big data platform, mapped into HHR, thereby enriching the patient’s longitudinal health record with valuable insights and interactions. Figure 2 depicts the internal workflow of the advanced monitoring mechanism.
 
 
Figure 2. Monitoring and Alerting internal workflow.
 
On the frontend side, the Monitoring and Alerting mechanism offers HCPs a React-based user interface (UI) to define offline rules and thresholds as part of the risk mitigation plans. The online evaluation of these rules in near real-time leads to dialogue proposals for the consideration of the HCPs, and the UI facilitates HCPs to make final selections for delivering the dialogues to patients. In that context, its main objective is to empower HCPs to assign mitigation plans and respective recommendations to a specific individual and then to monitor and assess the effect of these recommendations and plans in the lifestyle of the person. A mitigation plan is essentially an action plan assigned to a patient and typically the execution of this plan aims to bring concrete health improvements and to lower the risk of developing pancreatic cancer. It is comprised of several rules, some of which can be turned off, depending on the personalized configuration for the patient. The HCP will assign a goal value to each active rule of the mitigation plan selected for the patient. For example, a goal for a given patient can be to decrease the cigarettes smoked per day or to increase physical activity on a weekly basis. Then, the component will monitor and evaluate the progress of the patients by collecting and aggregating secondary (behavioral) data collected via the Healthentia mobile app, as self-reports or measurements, and then compare them with personalized targets issued by HCPs. To this end, Monitoring & Alerting enables the set of mitigation rules and facilitates the personalized interactions with the patients as depicted in Figure 3.
 
Figure 3. Inter-component communication.
 
The user journey begins when an HCP accesses the monitoring system’s UI through the DSS. This access point is the gateway to functionalities tailored to enhance patient care. It is also secured in compliance with the respective legal regulations towards an efficient access control and trustworthy data processing as described in Ref. 15. As shown in Figure 4, the HCP embarks on this process by assigning tailored mitigation plans and rules for each patient, which are crucial for guiding the patients towards healthier lifestyle choices and managing their health conditions effectively. After filling in all the settings, the HCP can see an overview of the assigned mitigation plan(s) for the current patient (Figure 5).
Figure 4. Configuration of mitigation plans.
 
 
 
Figure 5. Mitigation Plans Assignment in the advanced Monitoring and Alerting component.
 
Lowering or increasing one of the secondary data metrics is a feasible goal that can be assigned to a case. Such an example is the increase of the patient’s physical activity, by setting an attainable threshold (e.g., walking at least 10,000 steps a day), and trace it through physical data progress monitoring. Secondary data collection fluctuations of the past days/weeks, give information on the goal’s accomplishment or failure and drive possible re-evaluations from the health expert’s side or the machine learning algorithms of other components. The patients are informed of their progress or new assignments through the app dialogues served as push notifications to the Healthentia mobile app, and can also track their progress from the numerous widgets.
The iHelp platform supports two modes of communication of the outcomes derived from the evaluation of these rules: automatic communication of the evaluation results to the patient via the Healthentia API, or placing the outcomes in a pending state, requiring HCP’s approval before communication. This decision is pivotal as it dictates the subsequent flow of information and involves considerations of patient sensitivity, the gravity of the health information, and the need for personalized HCP intervention.
Following the initial setup, the monitoring system embarks on a continuous cycle of evaluation, operating in the background without the need for manual intervention. At every predefined interval, the system evaluates the patient’s data in relation to the assigned actions and rules. This automated process ensures timely assessment of the patient’s progress or adherence to personalized health goals.
If the HCP has opted for automatic communication, the system proceeds to inform the patient of their progress through the Healthentia API immediately after each evaluation cycle. This message or dialogue, encapsulating the outcome of the evaluation, is designed to be informative and motivational, fostering patient engagement with their health objectives. Furthermore, this continuous approach enables the iHelp platform to promote a way to enhance patient communication with an intelligent coaching element.10 In contrast, if the HCP prefers to review the evaluation outcomes before the patient communication, the system stores an overview of the potential message in the BDP with a “proposed” status. This holding pattern allows for HCP oversight, ensuring that all patient communications are vetted for accuracy, appropriateness, and clinical relevance.
Concurrently, an overview of this communication is archived within the Big Data Platform (BDP) for record-keeping and future reference, ensuring a comprehensive health history is maintained.
The next phase involves HCP interaction with the DSS, where proposed communications are presented for review. The HCP accesses these messages through the DSS interface, where each message is accompanied by a “Send” button. This interface offers HCPs the flexibility to approve or reject the communication based on clinical judgment and patient-specific considerations.
Upon clicking “Send,” the approved message is dispatched to the patient via the Healthentia API, with its status in the BDP updated to “approved.” Conversely, if the HCP decides against sending the message, its status is updated to “rejected” in the BDP, and the message is withheld from patient communication. This step underscores the critical role of HCPs in curating and validating health information communicated to patients.
This overall workflow should be also supported by low response times that are essential for maintaining engagement, clinical utility, and the wider adoption of the system. Given the dynamic interaction model involving both automated and HCP-reviewed messaging workflows, any delays in patient feedback (either automatic or HCP-approved) could compromise timely intervention or behavior change momentum. Hence, the evaluation tests of the system were critical and it should be highlighted that they demonstrated an average response time of approximately 300 ms for HCP interface operations (e.g., assigning a mitigation plan, reviewing patient alerts, approving message dispatch). Moreover, the backend service availability exceeded 99.35% in high-demand simulations, supporting real-time communication with patients via the Healthentia API.

 

Virtual coach

The Virtual Coach is a Healthentia component9 that offers patients the UI for receiving and interacting with the delivered content at the mobile application. As such the component runs on the Healthentia mobile app, which is used as the iHelp patient companion app (facilitating data collection and advice delivery1012). Behind the scenes, it exposes an endpoint for receiving requests for dialogue delivery from the M&A component. In that call, the receiving patient and the intended dialogue are identified. Upon receiving the request, Healthentia pushes a notification to the mobile operating system (Android or iOS). The patient can tap either on the notification of the operating system, or on the notification at the dedicated application page. Then, the mobile view of the virtual coach is displayed, and the patient can go through the dialogue (Figure 6). After dialogue playback, the patient can still see the notification in the dedicated page, along with a summary of what it was about as a reference. The dialogues are handled (authored and played back) in the virtual coach using the open-source WOOL platform.16
 
 
Figure 6. Handling dialogues at the Healthentia mobile app. A notification is sent to the patient (left), which leads to the dialogue playback UI (right).
 
The dialogue selection procedure depends on the nature of the message to be delivered, and can be carried out both by the iHelp system (health experts and ML models) or Healthentia’s decision making smart component – the Smart Profiler,17 detailed below. Both components leverage the patterns of the newly collected secondary data and perform evaluations on thresholds and goal achievements. The Monitoring and Alerting (M&A) component is responsible for triggering communications on achievements/failures of mitigation plans and introducing new actions to the end users. The dialogue content is triggered when the M&A rules indicate so. The Smart Profiler is responsible for choosing and triggering educational content, that appears to the users as tips on coping with the disease, the importance of their assigned actions, and the ways of achieving their goals adopting a healthier lifestyle. The educational content is also delivered in dialogues, daily selected by the Smart Profiler.

 

Smart profiler

The Smart Profiler is the intelligent system that makes decisions on advice delivery inside Healthentia.17 It decides which educational dialogue should be triggered for a given user, based on the user’s data. The Smart Profiler is an expert system, evaluating rules associated with each educational item. These rules allow enumerating the importance of each item, based on the user data at the given time. Each rule is represented in the database as a mathematical expression (see example below) and is associated with one or more dialogues.
Dialogue selection starts with the evaluation of all the rules associated with the candidate dialogues, returning the initial playback probability of each dialogue. These initial probabilities are further weighted based on frequency of dialogue repetition and on dialogue impact. The probability of a dialogue selected frequently in the recent past is penalized for the future, to avoid the repetition of the same content for the same user, and thus make the dialogues more interesting and engaging. Impact is calculated through evaluating the short-term effect of the dialogue. If the. This is calculated as the ratio of the probability evaluation at the time of selection, and the average probability in the coming 3 days. If the probabilities in at least short-term are reduced, then the Smart Profiler decides the dialogue has a positive impact. The initial probabilities are weighted by that ratio calculated the previous time the dialogue was played back, increasing them for impactful dialogues.
Besides rule evaluation, the Smart Profiler also considers the optimal time within the day for sending a notification to the user, based on app usage logging. The system maintains a histogram of interactions with the mobile app versus time of day. Given a time interval, the histogram yields the optimum time for the next communication. This feature ensures that the notification will reach the end-user at the most optimal time, for them to pay attention and interact with the app and the coach. Figure 7 shows the conceptual architecture of content delivery decisions and triggers in iHelp. Decisions and recommendations are made either internally by the Smart Profiler, or externally by the iHelp M&A, and the dialogue ID selected for triggering is eventually passed to the VC service, responsible to make the request for serving the content. The serving itself is managed via WOOL.
Figure 7. Internal and external decision making and triggering of a feedback dialogue for the Alerting component.
 
The mechanism described in Figure 7 works towards achieving changes in the lifestyle of patients. These changes are interrelated with better self-management when dealing with chronic diseases. Factors ranging from education and understanding of the principles of a condition to limiting behavioral risk factors in different domains of behavior enable a defense against multi-sided chronic illnesses effects: comorbidities, diminished mental health and exacerbations. The Smart Profiler focuses on six domains: Physical activity, sleep, nutrition, self-care, smoking cessation and emotional health. Healthentia’s dialogues delivered by the Virtual Coach address factors and habits that may lead to risk behaviors, aiming at extended lifespan and health span of patients. Successful interventions for life-changing actions must be underpinned by theoretically-driven behavior change models for long lasting results,18 the Smart Profiler implements the Behavior Change Wheel (BCW) intervention design by Michie et al., for delivering life changing content and advice.19 Out of the various frameworks designed to serve and drive behavioral change,20 BCW is an incorporation of 19 frameworks into a single coherent tool (Figure 8). The tool assesses the patient’s capability (C), opportunity (O), and motivation (M) for behavior (B) change (the COM-B model21). The behavioral change framework implemented within the Smart Profiler works along these three sources of human behavior, capability, opportunity and motivation, considering five intervention functions, namely Education, Training, Persuasion, Enablement and Incentivisation (out of the out of the nine functions introduced by the BCW). Different techniques can be applied for each intervention function, and Healthentia’s dialogues are assigned to these techniques. The Smart Profiler uses each patient’s contextual profile, including behavioral trends, current health goals, historical responses to dialogue types, and wearable/self-report data, to prioritize which intervention function (e.g., Persuasion vs Enablement) should be emphasized ensuring personalized behavioral alignment. For instance, a patient struggling with adherence might receive more persuasive and incentivizing dialogues, while one already engaged may receive educational reinforcement. This adaptive logic ensures that each dialogue delivered is behaviorally aligned and clinically relevant. The Smart Profiler ranks the domains, intervention functions and finally techniques, effectively selecting dialogues.
 
Figure 8. The Behavioral Change Wheel: The inner disk features the three sources of behavior, while the outer ring depicts the nine intervention functions, of which only the five in black are implemented within the Smart Profiler.
 

Discussion

The personalized dialogue and coaching system is an impactful innovation of the iHelp platform. It breaks the communication barriers between healthcare providers and receivers and facilitates behavioral change in patients and citizens by empowering them to understand their condition and providing easy to understand directions on how to manage their health. The rule-based dialogue selection system implemented in the Monitoring and Alerting mechanism effectively delivers personalized education and advice, thus impacting the everyday life of the patient or citizen at risk of developing cancer. Improved emphasis and understanding of the behavioral data can lead to improvements on the clinical condition of the patient, and change their lives for the better, as reported by the end-users of the solutions during the impact assessment performance. However, it is important to note that the questionnaires used to gather impact data were adapted from existing tools and pilot-tested but not formally validated for this specific study. To this end, there is the need to highlight that while the preliminary insights remain valuable, further validation in real-world setting and other use cases is envisioned to ensure the robustness and generalizability of the findings. Another limitation of this research work is that a thorough assessment of system usability, especially in the context of the HCP interface and patient-facing mobile app, was not feasible within the project’s timeline and this important dimension will be considered for inclusion in future work and projects.

 

Impact evaluator

The Impact Evaluator is responsible for evaluating the impact of the advice sent to groups of citizens/patients, as this advice is carried out via dialogues related to mitigation plans stemming from risk factors. It is shown in the overall iHelp architecture in Figure 1. The main goal is to monitor the behavior of citizens/patients and highlight to the HCPs how and if the specific type of advice changed the lifestyle of the recipients. For doing that, the citizens/patients are clustered using common characteristics (e.g. age, gender, BMI, or risk factors, if available) to compare the advice sent to a similar population). The result of this analysis should contribute to better finetune the model for generating the advice and the user to be reached. The input data is collected on demand of the HCP, both from the Monitoring and Alerting component (the goals, thresholds and their achievement) and the collected data (from the HHR using the standard FHIR API8). The impact is then evaluated, and the result is shown to the HCP through the dedicated iHelp platform interface.
The process is depicted in Figure 9. After clustering the advice recipients, the Impact Evaluator highlighted that for Topic1, a Cluster1 of people had a positive and healthy behavior after they received some prevention-based messages, but that was not the case for the promotion-based messages. Completely the opposite behavior was observed in Cluster2. Cluster3 of Topic1 remained unaffected. The percentage represented on the ordinate axis is the delta percentage of the achieved goal between the period before and after receiving the messages.
 
 
Figure 9. Clustering and Results. (a) Depicts the user journey and clustering approach of the Impact Evaluator; (b) Showcases an initial example of the final outcome.
 

Results

iHelp was evaluated during pilot studies that focused on the applicability of the clinical and technical outcomes through representative scenarios, while providing useful feedback about the iHelp concepts and technologies. Five pilot studies, carried out during the progress of the project, aimed to address three different aspects of the management of cancer: Primary prevention, Secondary prevention and Monitoring of treatments, while widening the field of types of cancers tackled to four, namely prostate, breast, anal and liver cancer. All pilots and technical partners worked in performing impact assessments (qualitative and quantitative) on both technological implementations and social factors, in the scope of prevention, early detection and treatment of cancer.
In all three cases the MA&F subsystem of iHelp delivered content to the patients. In total 600 items of content have been delivered. These span six domains: alcohol consumption (5.17% of the total content), general health including smoking cessation (9.83%), nutrition (15.5%), physical activity (23.5%), sleep (8.67%) and stress (37.3%). The patient then has the option to ignore or go through the content (complete it). Then they can choose to offer feedback on completed content. Some of it is positive. The volume of delivered, completed and positively received content across the different domains is shown in Figure 10.
 
 
Figure 10. Volume of delivered, completed and positively received content across the six domains.
 
While technological assessment is of high priority for any component made and destined to serve clinical studies, health experts and patients, the assessment of the impact of iHelp outcomes on socio-physical, mental and societal factors positively influencing a person’s health and life, remains the ultimate challenge. The evaluation of the program involved reports (questionnaires) to both clinicians participating in the study and end-users of the solution offered, on four main domains: physical, psychosocial, health knowledge and social aspects. Questionnaires were distributed online or on hospital premises after a specific timeframe of enrolment into the study or upon study completion, and the results are shown in Figure 11. It should be noted that these questionnaires were created and adapted based on existing instruments but were not validated for this specific study. They were, however, pilot-tested before deployment.
 
 
Figure 11. Evaluation of the iHelp solution impacts on patients’ lives.
 
 

Discussion

The personalized dialogue and coaching system is an impactful innovation of the iHelp platform. It breaks the communication barriers between healthcare providers and receivers and facilitates behavioral change in patients and citizens by empowering them to understand their condition and providing easy to understand directions on how to manage their health. The rule-based dialogue selection system implemented in the Monitoring and Alerting mechanism effectively delivers personalized education and advice, thus impacting the everyday life of the patient or citizen at risk of developing cancer. Improved emphasis and understanding of the behavioral data can lead to improvements on the clinical condition of the patient, and change their lives for the better, as reported by the end-users of the solutions during the impact assessment performance. However, it is important to note that the questionnaires used to gather impact data were adapted from existing tools and pilot-tested but not formally validated for this specific study. To this end, there is the need to highlight that while the preliminary insights remain valuable, further validation in real-world setting and other use cases is envisioned to ensure the robustness and generalizability of the findings. Another limitation of this research work is that a thorough assessment of system usability, especially in the context of the HCP interface and patient-facing mobile app, was not feasible within the project’s timeline and this important dimension will be considered for inclusion in future work and projects.
 

Conclusions

This research work introduced the conceptual design and prototype development of a novel patient monitoring system applied on advancing the early risk mitigation of pancreatic cancer. The prototype integrates a core Monitoring and Alerting component, supported by several sub-components and microservices based on a modular architecture. This design ensures interoperability and demonstrates the system’s ability to integrate with divergent mechanisms and components and a seamless deployment into real-world settings and environments. The latter is facilitated through the utilisation of clinical, behavioral, and patient-reported data, enabling HCPs to design and assign tailored mitigation plans, while supporting patients through adaptive coaching and continuous feedback.
Initial pilot evaluations presented in this manuscript highlighting the feasibility of the system in real-world healthcare environments. The qualitative and quantitative analysis of the results suggest that the platform can effectively deliver actionable insights and promote adoption of healthier behaviors by the individuals following personalized mitigation plans designed by their HCPs. Moreover, the clustering-based Impact Evaluator offers an evidence-driven approach to understanding how tailored feedback influences patient subgroups, thereby informing future refinements.
These achievements highlight the importance of designing and deploying scalable and patient-centered solutions in the modern healthcare landscape that also focus on integrating predictive analytics with personalized interventions and recommendations. This will further result to a more preventive, participatory, and data-driven model of care as HCPs will be empowered with advanced monitoring tools and patients will be engaged into a better management of their own health.
 

Acknowledgments

The authors wish to acknowledge the contribution of all the technical and medical partners of the iHelp consortium in setting up the iHelp platform and conducting the pilot studies.

 

Ethical considerations

This research was conducted under the scopes of the iHelp project. The pilot studies were conducted according to the guidelines of the Declaration of Helsinki and approved by the Research Ethics Committee of the Marina Salud S.A. (Ref: C.P. iHelp, C.I. 22/531-E; 3 October 2022), the Fondazione Policlinico Universitario Agostino Gemelli IRCCS – Comitato Etico, ID 4820, approval: 23/06/2022, amendment approval: 19/01/2023, the Medical University of Plovdiv Science Ethics Committee Protocol № 7/13.10.2022, Reg. № P 2504/11.11.2022, and the University Research Ethics Committee 3, Ref: 2022-13644-23283, approval date 09/05/2022. Written informed consent has been obtained from all subjects participated in these studies.

 

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

 

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the European Union’s project iHelp, grant number 101017441. This work has been partly supported by the University of Piraeus Research Center.
 

References
1. Paschou M and Sakkopoulos E. Personalized assistant apps in healthcare: a systematic review. In: Proceedings of the 2019 10th International Conference on Information, Intelligence, Systems and Applications (IISA), PATRAS, Greece, July 2019. IEEE, pp. 1–8.

2. Anthonia Okolo C, Babawarun O, Arowoogun JO, et al. Rawlings chidi the role of Mobile health applications in improving patient engagement and health outcomes: a critical review. Int J Sci Res Arch 2024; 11: 2566–2574.

3. Dhar E, Bah AN, Chicchi Giglioli IA, et al. A scoping review and a taxonomy to assess the impact of Mobile apps on cancer care management. Cancers 2023; 15: 1775.

4. Manias G, Op Den Akker H, Azqueta A, et al. iHELP: personalised health monitoring and decision support based on artificial intelligence and holistic health records. In: Proceedings of the 2021 IEEE Symposium on Computers and Communications (ISCC). Athens, Greece, September 5 2021: IEEE, pp. 1–8.

5. Manias G, Azqueta-Alz´uaz A, Damiani A, et al. An enhanced standardization and qualification mechanism for heterogeneous healthcare data. In: H¨agglund M, Blusi M, Bonacina S, et al. (eds). Studies in Health Technology and Informatics. IOS Press, 2023. ISBN 978-1-64368-388-1.

6. Manias G, Kouremenou E, Alz´uaz AA, et al. An optimized pipeline for the processing of healthcare data towards the creation of holistic health records. In: Proceedings of the 2023 International Conference on Applied Mathematics & Computer Science (ICAMCS), Lefkada Island, Greece, August 8 2023. IEEE, pp. 50–56.

7. Ke TM, Lophatananon A and Muir KR. Risk factors associated with pancreatic cancer in the UK bioban cohort. Cancers 2022; 14: 4991.

8. Manias G, Azqueta-Alz´uaz A, Dalianis A, et al. Advanced data processing of pancreatic cancer data integrating ontologies and machine learning techniques to create holistic health records. Sensors 2024; 24: 1739.

9. Op Den Akker H, Cabrita M and Pnevmatikakis A. Digital therapeutics: virtual coaching powered by artificial intelligence on real-world data. Front Comput Sci 2021; 3: 750428.

10. Kyriazakos S, Pnevmatikakis A, Cesario A, et al. Discovering composite lifestyle biomarkers with artificial intelligence from clinical studies to enable smart eHealth and digital therapeutic services. Front Digit Health 2021; 3: 648190.

11. Pnevmatikakis A, Kanavos S, Matikas G, et al. Risk assessment for personalized health insurance based on real-world data. Risks 2021; 9: 46.

12. Kyriazakos S, Pnevmatikakis A, Op Den Akker H, et al. The role of big data and artificial intelligence in clinical research and digital therapeutics. In: Cesario A, D’Oria M, Auffray C, et al. (eds). Personalized Medicine Meets Artificial Intelligence. Springer International Publishing, 2023, pp. 63–81. ISBN 978-3-031-32613-4.

13. Bove LA. Increasing patient engagement through the use of wearable technology. J Nurse Pract 2019; 15:535–539.

14. Narkhede N. Kafka: the definitive guide: real-time data and stream processing at scale. 1st ed. O’Reilly Media, 2016. ISBN 978-1-4919-3616-0.

15. Chen Y, Sun W, Zhang N, et al. Towards efficient fine-grained access control and trustworthy data processing for remote monitoring services in IoT. IEEE Trans Inf Forensics Secur 2019; 14: 1830–1842.

16. Beinema T, Op Den Akker H, Hofs D, et al. The WOOL dialogue platform: enabling interdisciplinary userfriendly development of dialogue for conversational agents. Open Res Europe 2022; 2: 7.

17. Beinema T, Op Den Akker H, Hermens HJ, et al. What to discuss? A blueprint topic model for health coaching dialogues with conversational agents. Int J Hum Comput Interact 2023; 39: 164–182.

18. Michie S and Abraham C. Interventions to change health behaviours: evidence-based or evidenceinspired? Psychol Health 2004; 19: 29–49.

19. Michie S, Van StralenMMandWest R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011; 6: 42.

20. Ara´ujo-Soares V, Hankonen N, Presseau J, et al. Developing behavior change interventions for selfmanagement in chronic illness: an integrative overview. Eur Psychol 2019; 24: 7–25.

21. Barker F, Atkins L and De Lusignan S. Applying the COM-B behaviour model and behaviour change wheel to develop an intervention to improve hearing-aid use in adult auditory rehabilitation. Int J Audiol 2016; 55: S90–S98.

 
Keywords: personalized healthcare, remote patient monitoring, behavioral change
 

 

More Publications

The post Advanced monitoring, alerting and feedback in early risk mitigation for pancreatic cancer appeared first on Healthentia.

]]>
22593
Enhancing Patient Adherence with B-COMPASS: A New Horizon for Digital Health Solutions https://healthentia.com/enhancing-patient-adherence-with-b-compass-a-new-horizon-for-digital-health-solutions/ Fri, 16 May 2025 11:17:01 +0000 https://healthentia.com/?p=22030 In the evolving landscape of digital health, understanding and supporting patient adherence to treatment remains a top priority especially in chronic disease management. Innovation Sprint is a proud partner of the Innovative Medicines Initiative IMI,  BEAMER project that addresses this need with the development of B-COMPASS (BEAMER-Computational Model for Patient Adherence and Support Solutions), a...

The post Enhancing Patient Adherence with B-COMPASS: A New Horizon for Digital Health Solutions appeared first on Healthentia.

]]>
In the evolving landscape of digital health, understanding and supporting patient adherence to treatment remains a top priority especially in chronic disease management. Innovation Sprint is a proud partner of the Innovative Medicines Initiative IMI,  BEAMER project that addresses this need with the development of B-COMPASS (BEAMER-Computational Model for Patient Adherence and Support Solutions), a novel, disease-agnostic model designed to decode the complexity of non-adherent behavior across diverse healthcare settings.

 

What Is B-COMPASS?

At its core, B-COMPASS helps all stakeholders in Healthcare from clinicians, caregivers, software providers, and healthcare policymakers to identify the drivers behind patient behavior. It relies on a concise set of fewer than ten questions to generate a patient profile based on five key dimensions: health consciousness, treatment needs, personal concerns, acceptance, and perceived control.

This simplicity makes it powerful. It enables the creation of tailored communication and support strategies to address the unique challenges each patient faces, ultimately aiming to improve adherence and treatment outcomes.

 

How Innovation Sprint Is Contributing

As a proud partner in the BEAMER project, Innovation Sprint brings deep experience in real-world data collection, behavioral modeling, and chronic disease management through our flagship Software as a Medical Device (SaMD), Healthentia.

With years of insights from managing patient journeys, particularly around non-adherence patterns, Innovation Sprint contributes to shaping and validating the B-COMPASS model with real-world scenarios. Our involvement ensures the model reflects actual patient needs and clinical realities, making it both usable and impactful in digital health platforms.

Through Healthentia, we have seen firsthand how variable patient engagement can be, and how crucial it is to adapt digital interventions to individual needs. Integrating tools like B-COMPASS enhances our ability to design adaptive programs that not only monitor but also positively influence patient behavior over time.

 

Why B-COMPASS Matters for SaMDs like Healthentia

Tools like B-COMPASS don’t just provide insight, they enable action. For SaMDs, this means gaining the ability to segment patients more meaningfully and respond with personalized interventions, educational content, and coaching.

The result? Increased treatment adherence, improved patient satisfaction, and reduced healthcare burden—goals at the heart of both BEAMER and Innovation Sprint’s mission.

 

Looking Forward

As B-COMPASS matures within the BEAMER framework, its integration into digital health ecosystems like Healthentia will further personalize chronic disease management. We believe this marks a pivotal step toward scalable, human-centered digital healthcare.

To learn more about B-COMPASS and the BEAMER project, visit https://beamerproject.eu/BEAMER-model/.

 

The post Enhancing Patient Adherence with B-COMPASS: A New Horizon for Digital Health Solutions appeared first on Healthentia.

]]>
22030
Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights https://healthentia.com/transforming-copd-care-with-healthentia-empowering-patients-and-providers-through-real-world-insights/ Wed, 20 Nov 2024 08:22:18 +0000 https://healthentia.com/?p=20589   Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires a comprehensive and innovative approach. As part of the RE-SAMPLE research project, Healthentia, our advanced SaMD solution, addresses this challenge by integrating real-world data (RWD) to enhance disease management and improve daily life for patients. For more information about the...

The post Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights appeared first on Healthentia.

]]>
 

Managing chronic obstructive pulmonary disease (COPD) alongside other chronic conditions (CCs) like depression requires a comprehensive and innovative approach. As part of the RE-SAMPLE research project, Healthentia, our advanced SaMD solution, addresses this challenge by integrating real-world data (RWD) to enhance disease management and improve daily life for patients. For more information about the intended use of the device and the medical modules, please consult: https://healthentia.com/medical-device/

This research-driven initiative bridges the gap between clinical research and real-world healthcare, supporting two phases of COPD and CCs management:

  • Phase 1: Healthentia collects RWD to track disease progression, uncover patterns, and predict exacerbations. These insights enable proactive care, empowering healthcare providers to anticipate and address patient needs more effectively.
  • Phase 2: Through its Virtual Companionship Program (VCP), the platform delivers tailored self-management tools, including lifestyle coaching, goal-setting, and real-time medical suggestions. Patients gain the confidence to manage their health actively, while healthcare providers benefit from actionable insights via a clinical dashboard. This enables personalized, adaptive care strategies, ensuring better outcomes.

Healthentia redefines the standard of COPD care in hospitals across Europe by seamlessly integrating real-world insights with technology-driven solutions. By prioritizing both patients and providers, it transforms the approach to managing not only COPD but also co-existing chronic conditions, helping patients regain control over their health and well-being.

This World COPD Day, Healthentia reaffirms its commitment to innovation, providing hope and support for millions living with COPD.

The post Transforming COPD Care with Healthentia: Empowering Patients and Providers through Real-World Insights appeared first on Healthentia.

]]>
20589
Risk Assessment for Personalized Health Insurance Products https://healthentia.com/risk-assessment-for-personalized-health-insurance-products/ Tue, 12 Mar 2024 12:18:08 +0000 https://healthentia.com/?p=20323 CATEGORY: Healthcare insurance, Explainable AI, Personalized healthcare, Real-world data, IoT, Big data SOURCE: Big Data and Artificial Intelligence in Digital Finance. Springer, Cham. https://link.springer.com/chapter/10.1007/978-3-030-94590-9_16 Risk Assessment for Personalized Health Insurance Products Kyriazakos S., Pnevmatikakis A., Perikleous A., Kanavos S. (2022) Abstract The way people lead their lives is considered an important factor in health. In...

The post Risk Assessment for Personalized Health Insurance Products appeared first on Healthentia.

]]>

CATEGORY: Healthcare insurance, Explainable AI, Personalized healthcare, Real-world data, IoT, Big data

SOURCE: Big Data and Artificial Intelligence in Digital Finance. Springer, Cham. https://link.springer.com/chapter/10.1007/978-3-030-94590-9_16

Risk Assessment for Personalized Health Insurance Products

Kyriazakos S., Pnevmatikakis A., Perikleous A., Kanavos S. (2022)

Abstract

The way people lead their lives is considered an important factor in health. In this chapter, we describe a system to provide risk assessment based on behavior for the health insurance sector. The system processes real-world data (RWD) of individuals from their daily life that enumerate different aspects of behavior collection. The data have been captured using the Healthentia platform and a simulator that augments the actual dataset with synthetic data. Classifiers are built to predict variations of peoples’ well-being short-term outlook. Risk assessment services are provided to health insurance professionals by processing the classifier predictions in the long term while explaining the classifiers themselves provide insights on the coaching of the users of the service.

Keywords: Healthcare insurance, Explainable AI, Personalized healthcare, Real-world data, IoT, Big data

 

More Publications

The post Risk Assessment for Personalized Health Insurance Products appeared first on Healthentia.

]]>
20323
World Health Day https://healthentia.com/world-health-day/ Fri, 07 Apr 2023 08:07:46 +0000 https://healthentia.com/?p=19772 World Health Day is celebrated every year on April 7th to raise awareness about global health issues and to promote healthy living. This year’s theme is “Building a Fairer, Healthier World” and it highlights the need for equal access to healthcare for all people. At Innovation Sprint, we believe that technology can play a crucial...

The post World Health Day appeared first on Healthentia.

]]>
World Health Day is celebrated every year on April 7th to raise awareness about global health issues and to promote healthy living. This year’s theme is “Building a Fairer, Healthier World” and it highlights the need for equal access to healthcare for all people.

At Innovation Sprint, we believe that technology can play a crucial role in creating a fairer and healthier world. Our product Healthentia is a medical decision support software that is designed to monitor, detect, and offer virtual coaching services to patients based on Real-World Data gathered from clinical investigations or from those using it as a medical or well-being device.
Healthentia helps healthcare professionals make informed decisions about patient care by providing them with real-time insights into patient health. It also helps patients take charge of their health by providing them with personalized coaching and alerts to help them manage their conditions.

In addition to using technology to improve healthcare outcomes, it’s important to also promote active living as a key component of a healthy lifestyle. Active living refers to incorporating physical activity into your daily routine, whether it’s through exercise, sports, or other physical activities. We believe that promoting active living is essential to building a fairer and healthier world. Healthentia not only offers virtual coaching services to patients, but it also encourages them to adopt healthy behaviors such as regular physical activity. We recognize that physical activity can have a positive impact on a wide range of health outcomes, including reducing the risk of chronic diseases such as heart disease, diabetes, and cancer. By promoting active living, we can help individuals improve their overall health and well-being, which can in turn lead to a fairer and healthier world for all.

On this World Health Day, let’s remember the importance of staying active and make a commitment to incorporating physical activity into our daily routines.
Together, we can use technology and promote active living to build a fairer and healthier world for everyone.

The post World Health Day appeared first on Healthentia.

]]>
19772
Use of Real-World Data in clinical research https://healthentia.com/use-of-real-world-data-in-clinical-research/ Mon, 16 Jan 2023 14:34:06 +0000 https://healthentia.com/?p=19617 Definition & importance Real-World Data (RWD) is any data relating to a patient’s health status, collected during the routine delivery of care, as opposed to data collected within the controlled setup of clinical trials. Hence RWD does not differ so much in its type but in the process and population involved in its collection. The...

The post Use of Real-World Data in clinical research appeared first on Healthentia.

]]>

Definition & importance

Real-World Data (RWD) is any data relating to a patient’s health status, collected during the routine delivery of care, as opposed to data collected within the controlled setup of clinical trials. Hence RWD does not differ so much in its type but in the process and population involved in its collection. The different types and sources of RWD can be:
  • Clinical data from electronic health records (EHRs) and case report forms (EHRs). This data establishes who the subject is, providing demographics, family history, comorbidities, procedure and treatment history, and outcomes. Such data types are also common in clinical trials.
  • Patient-generated data from patient-reported outcome (PRO) questionnaires, or measurements from wearables. This is data collected in everyday setting, providing insights directly from the patient, beyond clinic visits, procedures, and hospitalization. While patient-generated data is not unusual in clinical trials, it is collected in a centralized manner at the regular visits of the trial volunteers to the healthcare facilities. In the real-world context, the collection is done continuously at home.
  • Public and government data including cost and utilization data. Such data provides information on the healthcare system and the different stakeholders therein.
Such information can be used to create algorithms for risk stratification or to gain insight into associations between exposures, interventions, and outcomes. While clinical trials continue to be the main tool for studying the safety and efficacy of a new medicine, their controlled environment, and well-defined cohorts constitute experimental conditions that do not represent real-world settings. RWD is a much better tool for understanding how patients react to a medicine once approved and made available in the market, i.e., in routine medical care. The lack of highly controlled settings usually results in lower levels of confidence, but the outcomes represent a wider population of subjects. Such outcomes are better suited for understanding and taking decisions in everyday medical care, in broader settings than the controlled ones in clinical trials.  

RWD: Collecting in a clinical vs. everyday setting

There can be a huge quality difference between RWD collected in a clinical versus in everyday setting. In a clinical setting, the process is carried out sporadically by professionals, with subjects following strict guidelines (like time and method of collection, or diet prior to collection). In the everyday setting, the process is continuous and carried out by the subjects themselves. Whether the data is reported by the subjects or is measured by devices the subjects operate, the continuous nature and the self-supervision can lead to low quality due to device failure (usually uncharged devices, wearables not worn when they should have been, or mobile applications left unused for too long and automatically closed down) and lack of adherence (forgetting to answer instances of repeating questionnaires, amplified decline of interest in the process). Also, clinical data can be much more specialized to the medical conditions at hand, compared to most behavioral data collected in an everyday setting. But no matter these shortcomings when dealing with data collected in an everyday setting, it is now well-established that behavior is part of the intervention. The high specialization and quality of the sporadic clinical data is complemented by the continuous nature of the behavioral, everyday data, in much the same way a low-resolution film complements the understanding offered by the occasional high-resolution photo.  

Patient-generated, everyday RWD types

The behavioral, everyday RWD are categorized in terms of collection method and content. The following collection options are used:
  • Patient-reported via questionnaires: This collection model is closer to the established clinical trial approach, but this time the questionnaires are digital, pushed to subjects via some companion mobile app. They mostly have to do with self-assessment of different aspects.
  • Patient-reported via widgets: Similar to questionnaires, only this time rich graphical interfaces are employed. The widgets allow manual entry, or take advantage of integration with 3rd party devices meant for occasional use like scales or blood pressure monitors to automatically collect measurements.
  • Automatically reported by wearables: Continuous measurements from wearable devices is one of the most prominent sources of RWD. Ubiquitous activity trackers or more specialized devices like sleep monitors are integrated either at device level (when a Software Development Kit is available, e.g., via Apple Health Kit) or at device cloud level (when an Application Programming Interface is available).
  Using any of the above methods, the following everyday RWD types are collected:
  • Physiological: Data about physical activity, continuous monitoring of vitals, sleep
  • Psychological: Emotions
  • Social: Interactions (phone calls, social media)
  • Environmental: Living and working environment
 

Learning on RWD

At a raw level, RWD can lead to decisions about individuals and cohorts via analytics visualizations. But a full understanding of the context of subjects is gained via processing, using machine learning techniques. Supervised algorithms facilitate learning biomarkers, while unsupervised ones lead to phenotypes. RWD facilitates learning digital composite biomarkers. Biomarkers are quantities characterizing some disease or outcome. Digital refers to their attributes being ubiquitously available, not only as clinical data. Composite refers to the combination of multiple attributes in an attempt to predict some outcome. ML algorithms are used to learn outcome predictors as non-linear combinations of the attributes into the digital composite biomarkers. Phenotypes characterize the way the internal conditions of subjects manifest themselves for external observation. The different RWD attributes measured constitute the observation, and clusters of the observations correspond to different phenotypes. The clusters are learned from RWD using unsupervised ML algorithms. The clusters are then modeled for efficient representation of the phenotypes.  

RWD in Healthentia

Our product Healthentia is used to collect all types of patient-generated, everyday RWD types. Our subjects employ the Healthentia mobile app to answer questionnaires and to enter data via the widgets, either manually or using devices integrated via their Software Development Kits. Data collection also employs the Healthentia big data platform and ingests more subjects’ data using the Application Programming Interfaces of other device providers. The collected RWD is analyzed using the BI analytics available at the Healthentia portal for healthcare professionals. It is also processed using the smart services of Healthentia, namely:
  • The Learning Services for training models
  • The Inference Services for inferring with the help of the trained models
  • The Clinical Pathway for utilizing the raw RWD and the inference results in monitoring the state of subjects, and
  • The Virtual Coach for utilizing all the above in personalized advice given to the subjects.

The post Use of Real-World Data in clinical research appeared first on Healthentia.

]]>
19617
Healthentia at the edge: Healthentia services at the clinical data source https://healthentia.com/healthentia-at-the-edge-services-at-the-clinical-data-source/ Thu, 24 Nov 2022 08:58:05 +0000 https://healthentia.com/?p=19541 In many cases, clinical data cannot leave the premises of the healthcare organization that collects it. The comprehensive suite of Healthentia platform services for managing and processing data cannot address this issue. Instead, Innovation Sprint addresses the issue with specialized Healthentia edge services that facilitate data management and processing at the clinical data source. Thus,...

The post Healthentia at the edge: Healthentia services at the clinical data source appeared first on Healthentia.

]]>

In many cases, clinical data cannot leave the premises of the healthcare organization that collects it. The comprehensive suite of Healthentia platform services for managing and processing data cannot address this issue. Instead, Innovation Sprint addresses the issue with specialized Healthentia edge services that facilitate data management and processing at the clinical data source. Thus, we increase the capabilities and resources at the hands of healthcare professionals, when they are working with data from different clinical sources, but also when mixed with real-world data from Healthentia. Specifically, the Healthentia edge services offer operational improvements in two important aspects, the provision of clinical data in the familiar Healthentia portal application, and the learning and use of composite clinical and behavioral models.

The Healthentia subject-level dashboard is enriched with clinical data using the Local Data Connector (LDC). LDCs are installed at hospital premises to facilitate the proper visualization of clinical data about a particular patient in the Healthentia subject-level dashboard, while the clinical data remains at the edge, without being ingested into the Healthentia platform. As a result, healthcare professionals have at their disposal a richer set of resources (composite clinical and real-world data analytics), improving their analytics experience by eliminating the need to use different tools and offering them more decision capabilities. LDCs are configured per hospital, to abstract the particularities of hospital information systems and create a message to be consumed by the browser, rendering the visualizations using metadata in the message along with the actual payload to be displayed.

The learning of composite clinical and behavioral models is also done at the edge (premises of the healthcare institution) utilizing edge installations of the Local Learning Services (LLS). The LLS facilitates model learning at the edge, employing the Innovation Sprint algorithms at the premises of the healthcare institutions, combining there the clinical and the Healthentia real-world data, formatting it into feature vectors suitable for learning models, and running the machine learning algorithms. The application of the resulting composite clinical and behavioral models enhances the healthcare professionals’ decision capabilities.

The use of the composite models is also done at the edge, employing the Local Inference Services (LIS) Healthentia edge service. LIS is an online service that also builds composite vectors, this time for online inference. The LIS then performs inference and transmits the inference results to the Healthentia platform.

The first version of the LDC and the LLS is being built in the context of the TERMINET project, as part of the TERMINET edge architecture. Stay tuned for news on their application in the SUPERO study that is now starting to enroll its first patients!

The post Healthentia at the edge: Healthentia services at the clinical data source appeared first on Healthentia.

]]>
19541
TERMINET https://healthentia.com/terminet/ Thu, 27 Oct 2022 11:33:14 +0000 https://healthentia.com/?p=19515 Study Description TERMINET will validate and demonstrate six proof-of-concept, realistic use cases in compelling IoT domains such as energy, smart buildings, smart farming, healthcare, and manufacturing. Study Details Type: H2020 Disease:  Cancer Start: November 2020 Duration: 36 months Project's Challenges The vision of TERMINET is to provide a novel next-generation reference architecture based on cutting-edge...

The post TERMINET appeared first on Healthentia.

]]>

Study Description

TERMINET will validate and demonstrate six proof-of-concept, realistic use cases in compelling IoT domains such as energy, smart buildings, smart farming, healthcare, and manufacturing.

Study Details

  • Type: H2020
  • Disease:  Cancer
  • Start: November 2020
  • Duration: 36 months

Project's Challenges

The vision of TERMINET is to provide a novel next-generation reference architecture based on cutting-edge technologies such as SDN, multiple-access edge computing, and virtualization for next-generation IoT while introducing new, intelligent IoT devices for low-latency, market-oriented use cases and validation scenarios.

Our Role

Innovation Sprint’s role is to utilize Healthentia to collect patient data from four departments of Policlinico Gemelli ie. pathology, radiation oncology, and radiology departments, collaborating with them on running the Use case 2: Pathway of Personalised health care. To do so, we are involved in use case demonstration scenarios, requirements collection, and TERMINET’s reference architecture. We will exploit pervasive sensing devices to collect healthcare-related data from wearable devices (e.g., ECG sensor, blood pressure sensor, wristbands etc.) worn on human bodies, as well as medical history data based on legacy and modern medical devices inside the hospital.

We are integrating and testing the system, to run a pilot and evaluate its results. Finally, we are involved in the dissemination, market analysis, and exploitation activities of the project.

Consortium Partners

Project Type: PRECISION HEALTH REAL-WORLD DATA & WEARABLES

 — H2020 EUROPEAN-FUNDED PROJECT

The post TERMINET appeared first on Healthentia.

]]>
19515
AZIMUTH https://healthentia.com/azimuth_heartfailure/ Tue, 26 Jul 2022 11:50:25 +0000 https://healthentia.com/?p=19472   Study Description AZIMUTH model of care is delivered through Healthentia; a Software as a Service (SaaS) medical device via a mobile application for patients and a clinical dashboard for clinicians for Remote Patient Monitoring (RPM), Patient Support Programs (PSP) and Digital Therapeutics (DTx). This innovative scalable model of personalised remote heart failure care is based on...

The post AZIMUTH appeared first on Healthentia.

]]>

 

Study Description

AZIMUTH model of care is delivered through Healthentia; a Software as a Service (SaaS) medical device via a mobile application for patients and a clinical dashboard for clinicians for Remote Patient Monitoring (RPM), Patient Support Programs (PSP) and Digital Therapeutics (DTx). This innovative scalable model of personalised remote heart failure care is based on good clinical practice standards and international guidelines for heart failure management and has been designed taking into consideration both the optimization of in-hospital care delivery models as well as the often unmonitored out-of-hospital and home settings

The first phase of the study has successfully validated the feasibility, patient acceptance and perceived value of the app-based model of care, demonstrating increased user engagement in patients that leads into improved adherence to treatment.

Dr. Domenico D’Amario

Senior Cardiologist at the Gemelli IRCCS Polyclinic Foundation

Study Details

  • Type:  Interventional
  • Disease:  Heart Failure – Chronic Ischemic Disease
  • Sites: Fondazione Policlinico Gemelli
  • Start:  Phase 1: Nov-March 2021, Phase 2: Jul-Jan 2023
  • Population: 300 patients
  • Duration: Multiphase project

 

Study Design & Method

Heart failure is the leading cause of death and hospitalisation in patients aged > 65 years and a major and growing medical and economic burden, with high prevalence and incidence rates worldwide. The recent pandemic crisis has made even more evident, some critical aspects in the management of complex chronic diseases, such as heart failure, and these could be exacerbated by the increased demand for care in the future. Therefore, a significant effort must be made to align services with patients’ care needs by identifying a shared model that can exploit the most advanced technologies to enhance disease deterioration, provide adequate integration between hospital and territorial services, increase appropriateness, and reduce waiting times for specialist services.

Testimonial

The care pathway for patients with heart failure includes several steps, from acute phase treatments to chronic phase patient follow-up. This requires a close dialogue between hospital cardiologists and community medicine, especially once the patient returns home, after being discharged from a third-level hospital. But at the moment this complex path is very fragmented.

Group 227

Validated the feasibility, patient acceptance and perceived value of remote patient monitoring

9122021(1)

Demonstrating increased user engagement in patients that leads into improved adherence to treatment

The post AZIMUTH appeared first on Healthentia.

]]>
19472